logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Ascletis Pharma-B (01672.HK) repurchased 200,000 shares for HK$1.3428 million on October 13.

date
13/10/2026
Zhitong Finance APP news, Ascletis Pharma-B (01672.HK) announced that on October 13, 2026, it spent HK$1.3428 million to repurchase 200,000 shares.
Latest
1 m ago
UnitedHealth (UNH.US) Q3 results beat expectations: lower medical loss ratio boosts profit, full-year earnings guidance raised again
2 m ago
Guotai Haitong (02611.HK) appoints Zhang Xinjun concurrently as the company's Chief Risk Officer
2 m ago
J&T Express-W (01519.HK) repurchased 2.6 million shares for HK$23.9515 million on October 13.
4 m ago
Renault Group CEO: If the EU does not relax its 2030 CO2 emissions targets, Renault may have to cut European production by 300,000 vehicles.
4 m ago
Chuantou Energy (600674.SH) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 4.405 billion, a year-on-year increase of 4.36%.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.